Mirae Asset Global Investments Co., Ltd. Moderna, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 101,234 shares of MRNA stock, worth $4.27 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
101,234
Previous 82,484
22.73%
Holding current value
$4.27 Million
Previous $9.79 Million
30.93%
% of portfolio
0.03%
Previous 0.05%
Shares
20 transactions
Others Institutions Holding MRNA
# of Institutions
954Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.79 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.7 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.08 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$711 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$305 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $16.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...